Archived

This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.

US Patent Number

10,864,212

Publication Date

12-15-2020

Abstract

The present disclosure relates to compositions and methods for treating retinal damage and/or retinal degradation. More specifically, this disclosure relates to methods for treating degradation of the retinal pigment epithelium by administering compositions comprising a nucleoside and/or a nucleoside or nucleotide reverse transcriptase inhibitor.

Assignees

University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

16/361,810

Filing Date

3-22-2019

Included in

Ophthalmology Commons

Share

COinS